Rapid recovery in a child with febrile ulceronecrotic Mucha-Habermann disease following intravenous immunoglobulin administration
© 2024 Wiley Periodicals LLC..
Febrile ulceronecrotic Mucha-Habermann disease (FUMHD), a lymphocyte-mediated inflammatory skin disorder, is considered a severe variant of pityriasis lichenoides et varioliformis acuta that can lead to a fatal outcome if not managed in a timely fashion. Children with FUMHD can have systemic complications involving various organs. The scarcity of reported cases and the absence of well-designed studies or randomized clinical trials to evaluate different therapeutic modalities pose a major challenge in treating this potentially life-threatening disorder. We report a five-year-old child with FUMHD and seizures treated unsuccessfully with a combination of systemic steroids, methotrexate, dapsone, and oral erythromycin, who improved rapidly and achieved disease control with just a single infusion of low-dose intravenous immunoglobulin.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Pediatric dermatology - (2024) vom: 17. Jan. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Somasundaram, Arun [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Revised 18.01.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1111/pde.15516 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367245930 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM367245930 | ||
003 | DE-627 | ||
005 | 20240118232219.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240118s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/pde.15516 |2 doi | |
028 | 5 | 2 | |a pubmed24n1263.xml |
035 | |a (DE-627)NLM367245930 | ||
035 | |a (NLM)38234081 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Somasundaram, Arun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rapid recovery in a child with febrile ulceronecrotic Mucha-Habermann disease following intravenous immunoglobulin administration |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 18.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 Wiley Periodicals LLC. | ||
520 | |a Febrile ulceronecrotic Mucha-Habermann disease (FUMHD), a lymphocyte-mediated inflammatory skin disorder, is considered a severe variant of pityriasis lichenoides et varioliformis acuta that can lead to a fatal outcome if not managed in a timely fashion. Children with FUMHD can have systemic complications involving various organs. The scarcity of reported cases and the absence of well-designed studies or randomized clinical trials to evaluate different therapeutic modalities pose a major challenge in treating this potentially life-threatening disorder. We report a five-year-old child with FUMHD and seizures treated unsuccessfully with a combination of systemic steroids, methotrexate, dapsone, and oral erythromycin, who improved rapidly and achieved disease control with just a single infusion of low-dose intravenous immunoglobulin | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a IVIg | |
650 | 4 | |a PLEVA (pityriasis lichenoides et varioliformis acuta) | |
650 | 4 | |a febrile ulceronecrotic Mucha-Habermann disease (FUMHD) | |
650 | 4 | |a intravenous immunoglobulins | |
700 | 1 | |a Gupta, Ankan |e verfasserin |4 aut | |
700 | 1 | |a Sathishkumar, Dharshini |e verfasserin |4 aut | |
700 | 1 | |a Mathew, Lydia |e verfasserin |4 aut | |
700 | 1 | |a George, Anju |e verfasserin |4 aut | |
700 | 1 | |a Thomas, Meera |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pediatric dermatology |d 1986 |g (2024) vom: 17. Jan. |w (DE-627)NLM012965154 |x 1525-1470 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:17 |g month:01 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/pde.15516 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 17 |c 01 |